LXRX FY 2009 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$722M

FY 2009 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$11M-66.9% YoY

Gross Profit

$11M100.0% margin

Operating Income

-$90M-840.7% margin

Net Income

-$83M-773.6% margin

EPS (Diluted)

$-3.98

Cash Flow

Operating Cash Flow

-$89M

Free Cash Flow

-$89M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$258M

Total Liabilities

$94M

Stockholders' Equity

$164M

Cash & Equivalents

$101M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$32M	-66.9%
Gross Profit	$11M	$32M	-66.9%
Operating Income	-$90M	-$97M	+6.8%
Net Income	-$83M	-$77M	-7.7%